Clinical Trial Update: Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating botulinum therapy for early post-stroke spasticity in Asian population; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasticity
• Stroke

Drugs mentioned

• Botulinum (Asian trial)

Snippet

Sponsor: Ipsen | Conditions: Muscle Spasticity, Cerebrovascular Accident | Phase 4 | Status: COMPLETED